Iobenguane sulfate i-131 - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for iobenguane sulfate i-131 and what is the scope of freedom to operate?
Iobenguane sulfate i-131
is the generic ingredient in one branded drug marketed by Pharmalucence and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for iobenguane sulfate i-131
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 4 |
DailyMed Link: | iobenguane sulfate i-131 at DailyMed |
Recent Clinical Trials for iobenguane sulfate i-131
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
United Therapeutics | Phase 1 |
New Approaches to Neuroblastoma Therapy Consortium | Phase 1 |
Children's Oncology Group | Phase 3 |
US Patents and Regulatory Information for iobenguane sulfate i-131
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmalucence | IOBENGUANE SULFATE I 131 | iobenguane sulfate i-131 | INJECTABLE;INJECTION | 020084-001 | Mar 25, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for iobenguane sulfate i-131
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pharmalucence | IOBENGUANE SULFATE I 131 | iobenguane sulfate i-131 | INJECTABLE;INJECTION | 020084-001 | Mar 25, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |